Zimmer Biomet Holdings, Inc. (ZBH) — Fair Value Analysis

Base-case fair value (P50): $107.78 · Current price: $100.65 · Verdict: Fairly Valued

The Verdict on ZBH

Our Monte Carlo simulations indicate Zimmer Biomet (ZBH) is currently Fairly Valued. At $100.65, ZBH trades below our median fair value estimate of $107.78, suggesting a potential +7.1% upside based on thousands of simulated future paths. While this upside exists, the probability distribution derived from our analysis places $100.65 squarely within ZBH's probabilistic fair value range, preventing an "undervalued" verdict. This assessment reflects a balanced outlook, where the current market price adequately captures the company's intrinsic value, as modeled through diverse economic and operational scenarios.

How ZBH stacks up against Healthcare

Within the Healthcare sector, ZBH exhibits an average quality tier, reflecting its operational and financial health relative to peers. This average standing implies that while ZBH is not deeply undervalued, its current valuation at $100.65 provides a reasonable entry point compared to its intrinsic value, represented by $107.78. The Monte Carlo simulation accounts for this quality tier in modeling potential revenue growth and margin fluctuations across diverse economic conditions, from downside scenarios to more optimistic bull cases, helping to define the range around $107.78. This comprehensive approach ensures that the sector context is fully integrated into our fair value assessment.

What this means for investors

For investors, the Fairly Valued assessment of ZBH suggests that the current price of $100.65 adequately reflects its intrinsic worth, with the +7.1% indicating a modest buffer for potential appreciation. Given its average quality tier in the Healthcare sector, ZBH presents a balanced risk-reward profile, with the median fair value of $107.78 serving as a central estimate from our probabilistic modeling. FairCurve's Monte Carlo analysis provides a dynamic perspective on ZBH's valuation, considering thousands of potential future paths to arrive at its Fairly Valued verdict. Sign up for a free FairCurve account to see the full bear/bull distribution and track ZBH's fair value as new fundamentals are released.